In particular, we showed the increased expression of BRAF in treated cells compared to untreated cells (NT), that is more evident in melanoma cells treated with (Bu3Sn)4TPPS (Figure 4A–C, middle and right panels). This evidence concerns the gene BRAF and melanoma.